PATIENT PREFERENCE, SAFETY AND EFFICACY OF MIRABEGRON VS SOLIFENACIN IN PATIENTS WITH PELVIC ORGAN PROLAPSE AND OVERACTIVE BLADDER: A RANDOMIZED CROSSOVER PILOT STUDY